悪性黒色腫
WordNet
- evil or harmful in nature or influence; "prompted by malign motives"; "believed in witches and malign spirits"; "gave him a malign look"; "a malign lesion"
- any of several malignant neoplasms (usually of the skin) consisting of melanocytes (同)malignant_melanoma
PrepTutorEJDIC
- 《名詞の前にのみ用いて》(物事が)悪影響のある,有害な(injurious) / (人が)悪意のある(malicious);(…に)悪意のある《+『to』(『toward』)+『名』》 / …‘を'中傷する,けなす(slander)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Cytomorphology of unusual primary tumors in the Pap test.
- Khalbuss WE, Pantanowitz L, Monaco SE.Author information Address: Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.AbstractRare entities in the Pap test, which include neoplastic and non-neoplastic conditions, pose challenges due to the infrequent occurrence of many of these entities in the daily practice of cytology. Furthermore, these conditions give rise to important diagnostic pitfalls to be aware of in the Pap test. For example, cases with adenoma malignum (AM) have been called benign. Recognition of these conditions can help correctly interpret Pap tests as abnormal and thereby ensure that patients get appropriately diagnosed. In this paper, we illustrate and discuss selected uncommon primary neoplastic lesions of the cervix and the vagina that may be seen in Pap test, with a focus on cytomorphology, differential diagnosis and the role of possible ancillary studies. These cases include high-grade squamous intraepithelial lesion cells with small cell morphology; small cell carcinoma; large neuroendocrine carcinoma; glassy cell carcinoma; AM; malignant mixed Müllerian tumor; clear cell carcinoma and primary malignant melanoma. Recognition of these rare variants/neoplasms is important so that involved Pap tests are not diagnosed as benign and that patients with these conditions get additional follow-up.
- CytoJournal.Cytojournal.2013 Aug 30;10:17.
- Rare entities in the Pap test, which include neoplastic and non-neoplastic conditions, pose challenges due to the infrequent occurrence of many of these entities in the daily practice of cytology. Furthermore, these conditions give rise to important diagnostic pitfalls to be aware of in the Pap test
- PMID 24082913
- Evaluation of melanogenesis in A-375 melanoma cells treated with 5,7-dimethoxycoumarin and valproic acid.
- Chodurek E, Orchel A, Orchel J, Kurkiewicz S, Gawlik N, Dzierżewicz Z, Stępień K.Author information Department of Biopharmacy, Medical University of Silesia, Sosnowiec, Poland. echodurek@sum.edu.plAbstractMalignant melanoma (melanoma malignum) is one of the most dangerous types of tumor. It is very difficult to cure. In recent years, a lot of attention has been given to chemoprevention. This method uses natural and synthetic compounds to interfere with and inhibit the process of carcinogenesis. In this study, a new treatment strategy was proposed consisting of a combination of 5,7-dimethoxycoumarin (DMC), an activator of melanogenesis, and valproic acid (VPA), a well-known drug that is one of the histone deacetylase inhibitors (HDACis). In conjunction with 1 mM VPA, all of the tested concentrations of DMC (10-150 μM) significantly decreased the proliferation of A-375 cells. VPA and DMC also induced the synthesis of melanin and the formation of dendrite and star-shaped cells. Tyrosinase gene expression and tyrosinase activity significantly increased in response to VPA treatment. Pyrolysis with gas chromatography and mass spectrometry (Py-GC/MS) was used to investigate the structure of the isolated melanin. This showed that the quantitative and qualitative components of melanin degradation products are dependent on the type of applied melanogenesis inductor. Products derived from eumelanin were detected in the pyrolytic profile of melanin isolated from A-375 cells stimulated with DMC. Thermal degradation of melanin isolated from melanoma cells after exposure to VPA or a mixture of VPA and DMC revealed the additional presence of products derived from pheomelanin.
- Cellular & molecular biology letters.Cell Mol Biol Lett.2012 Dec;17(4):616-32. Epub 2012 Sep 20.
- Malignant melanoma (melanoma malignum) is one of the most dangerous types of tumor. It is very difficult to cure. In recent years, a lot of attention has been given to chemoprevention. This method uses natural and synthetic compounds to interfere with and inhibit the process of carcinogenesis. In th
- PMID 23001511
- Tissue-specific homing of immune cells in malignant skin tumors.
- Jókai H, Marschalkó M, Csomor J, Szakonyi J, Kontár O, Barna G, Kárpáti S, Holló P.Author information Department of Dermatovenerology and Dermatooncology, Semmelweis University, Mária u. 41, Budapest, 1085, Hungary. jokaihajnalka@gmail.comAbstractTissue-specific migration of immune cells involved both in physiological and pathological immune responses is a current research subject for medical science. Several homing molecules have been identified orchestrating extravasation of immune cells to certain peripheral non-lymphoid tissues such as gut, lung and skin. Regarding lymphocyte homing to skin, the first-line defense of human body cutaneous lymphocyte associated antigen (CLA) and a group of chemokine-chemokine receptor pairs are considered to be of crucial importance. The aim of the present review is to summarize existing knowledge about skin- and tumor-specific migration of immune cells playing a major pathogenetic role in host immune responses induced by non-lymphoid malignant skin tumors as well as in the development of primary cutaneous T-cell lymphomas (CTCL). Melanoma malignum, squamous and basal cell carcinoma evoke host immune responses and consequently a subset of reactive immune cells is recruited to site of the tumor. Regarding migratory process and exact functional role of these cells a growing number of data is available in literature. On the other hand tissue-specific immune cell homing is regarded as a key process in the pathogenesis of CTCL where malignant T-lymphocytes can be found in circulation and symptomatic skin. Hereby homing mechanism of malignant T-cells in mycosis fungoides and Sézary-syndrome as separate clinical entities of CTCL is discussed. A precise insight into the molecular background of skin- and tumor-specific immune cell migration can contribute to developing efficient vaccine therapies in non-lymphoid malignant skin tumors and beneficial treatment modalities in CTCL.
- Pathology oncology research : POR.Pathol Oncol Res.2012 Oct;18(4):749-59. Epub 2012 Apr 24.
- Tissue-specific migration of immune cells involved both in physiological and pathological immune responses is a current research subject for medical science. Several homing molecules have been identified orchestrating extravasation of immune cells to certain peripheral non-lymphoid tissues such as g
- PMID 22528565
Japanese Journal
- 討論 (癌の発生と癌細胞性状の諸問題 第26回日本癌学会総会シンポジウム記録) -- (メラノーマ(悪性黒色腫,Melanoma malignum))
- マウス・メラノーマの培養細胞におけるメラニン合成 (癌の発生と癌細胞性状の諸問題 第26回日本癌学会総会シンポジウム記録) -- (メラノーマ(悪性黒色腫,Melanoma malignum))
- 末梢神経線維の腫瘍 (癌の発生と癌細胞性状の諸問題 第26回日本癌学会総会シンポジウム記録) -- (メラノーマ(悪性黒色腫,Melanoma malignum))
Related Links
- Melanoma Malignum - Melanoma is discussed in detail. Also, learn about the effective natural remedies that completely cure the deadly disease. ... Non-Hodgkin’s Lymphoma Stage Iii Malignant Mesothelioma Lung Cancer »
- Melanoma malignum on the left leg of a 60-year-old woman ICD-10 C 43. ICD-9 172 ICD-O: M 8720/3 OMIM 155600 DiseasesDB 7947 MedlinePlus 000850 Melanoma Microchapters Home Patient Information Overview Causes ...
★リンクテーブル★
[★]
- 英
- malignant melanoma MM
- 同
- メラノーマ melanoma
- ラ
- melanoma malignum
- 関
- メラニン尿
概念
悪性黒色腫のABCDE NDE.421
頭文字
|
特徴
|
A
|
Asymmetry
|
不規則形
|
B
|
Borderline irregularity
|
境界不鮮明
|
C
|
Color variegation
|
色調多彩
|
D
|
Diameter enlargement
|
拡大傾向(直径6mm以上)
|
E
|
Elevation of surface
|
表面隆起
|
疫学
- 人口10万対:白人10~20、日本人1~2、黒人1以下
- 白人では体幹や四肢に好発し,表在拡大型が大多数を占める。日本人では足底や爪部(爪下黒色腫subungual melanoma)など四肢末端部に好発し,末端黒子型が多い
病変形成&病理
発生母地
臨床像による分類
- 悪性黒子から移行する。
- 高齢者の顔面に好発。
- 他の3型に比べて予後が良好。
- 四肢末端(特に足底)、爪、粘膜に生じ、日本人に多い。
- 褐色ないし黒色の斑として生じ、浸潤性に増殖すると結節をつくる。
- Hutchinson徴候-爪では縦に黒色線状を呈し、爪溝を越えて色素斑が拡大する。
- はじめ水平方向に扁平隆起性に拡大し、やがて垂直方向に浸潤増殖する。
- 褐色ないし、黒色の斑点として生じる。
- 垂直方向に浸潤増殖して結節を形成し、水平方向には展開しない。
- 予後が悪い。
- 色素を欠き、白くなるものもある。
ダーモスコピー所見
- 皮丘有意な色素沈着。感度86%, 特異度99% → 皮丘優位ではないことを検討してメラノーマを除外しよう! Nikkei Medical 2005 pp.116
- メラノーマでは86%に皮丘優位の色素沈着あり
- メラノーマでないとき、99%が皮丘優位ではない
治療
- modality:(第一選択)外科治療、放射線療法、化学療法、免疫療法
ガイドライン
- 1. Clinical Question - 悪性黒色腫 - 日本皮膚科学会
- http://www.dermatol.or.jp/medical/guideline/skincancer/cq.html#mm
- 2. アルゴリズム - 悪性黒色腫 - 日本皮膚科学会
- http://www.dermatol.or.jp/medical/guideline/skincancer/mm/mm.html
[★]